Vulnerability in Sooil Anydana-a
CVE-2020-27269
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physic…
EPSS: 0.005 (39.6th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 5.7 (Medium). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N.
Affected products
- Sooil Anydana-a
- Sooil Anydana-a_firmware
- Sooil Anydana-i
- Sooil Anydana-i_firmware
- Sooil Diabecare_rs
- Sooil Diabecare_rs_firmware
- N/a Sooil Developments Co., Ltd Diabecare Rs, Anydana-i And Anydana-a — versions Dana Diabecare RS, AnyDana-i, AnyDana-A All versions prior to 3.0
Weakness classification (CWE)
References
- ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)
Frequently asked questions
- What is CVE-2020-27269?
- CVE-2020-27269 is a medium-severity vulnerability in Sooil Anydana-a, classified under Authentication Bypass by Capture-replay. CVSS score: 5.7/10. Published 2021-01-19.
- How severe is CVE-2020-27269?
- Medium severity. CVSS v3 base score is 5.7 out of 10.